RecruitingNCT06137885

REgiStry-based Cardiovascular qUality improvEment Research

Registry-based Cardiovascular Quality Improvement Research (RESCUER)


Sponsor

Peking University Third Hospital

Enrollment

2,000 participants

Start Date

Apr 24, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this registry-based observational study is to establish a comprehensive management plan, which focus on medical therapy, cardiac rehabilitation and active post-market surveillance of medical devices, in patients with cardiovascular diseases (CVD). Patients with CVD mainly refers to four groups of patients:1) post-percutaneous coronary intervention (post-PCI) patients; 2) patients with heart failure (HF); 3) patients with cardiometabolic diseases (CMD); 4) patients with structural heart disease (SHD), and the detailed definition of each group can be found in "Eligibility" section. The main questions this study aims to answer are: * the effectiveness of exercise-based cardiac rehabilitation in improving cardiac function, reducing CVD recurrence and mortality, and promoting quality of life for patients with CVD; * the feasibility of registry-based active post-market surveillance of high-risk medical devices used in cardiovascular surgeries, such as PCI, heart valve replacement, and cardiac resynchronization therapy (CRT); * the utilization of multiomics datasets to identify and dissect cardiovascular heterogeneity in both healthy and diseased populations and to guide precision medicine in patients with CVD; * the analysis and evaluation of the prescription patterns and drug response in patients with CVD.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This is a registry-based study collecting data from heart disease patients hospitalized at Peking University Third Hospital in China. The goal is to study cardiovascular care quality and outcomes across different groups, including those who received heart procedures, those with heart failure, and those with combined heart and metabolic conditions. **You may be eligible if...** - You are 18 or older - You are hospitalized at the Cardiology Department of Peking University Third Hospital after April 24, 2023 - You fall into one of these groups: you had a coronary artery procedure (PCI or angiogram), you have heart failure, or you have both cardiovascular disease and a metabolic condition (such as diabetes or obesity) **You may NOT be eligible if...** - You do not have one of the qualifying cardiovascular conditions - You are under 18 years of age - You are not being treated at the participating hospital Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALCardiac rehabilitation

Cardiac rehabilitation is a comprehensive model of care involving prescribed exercise, medication management, lifestyle modification, and psychosocial counseling to help people with heart diseases resume and enhance their psychosocial and vocational status.

OTHERActive post-market surveillance of devices

Active post-market surveillance of devices is an essential and ongoing process that involves systematic monitoring and assessment of medical devices once they are available on the market. It involves continuous data collection and analysis, early detection of issues, risk assessment, compliance with regulatory requirements, adaptive decision-making, and transparent communication with healthcare professionals and patients.

OTHERMulti-omics approach to precision medicine

Multi-omics analysis refers to the collective analysis of extensive biological data from multiple omics sources to gain a holistic understanding of an individual's health status, disease susceptibility, and response to therapies. By considering a broad spectrum of genetic and molecular information, multi-omics precision medicine aims to deliver more accurate diagnoses, predict disease risks, select optimal treatment options, and monitor therapeutic responses with a high degree of specificity, ultimately improving patient outcomes and minimizing adverse effects.

OTHERThe prescription pattern analysis

The prescription pattern analysis refers to the systematic examination and evaluation of the types, dosages, frequencies, and trends in medications prescribed to patients with cardiovascular conditions. By scrutinizing prescription patterns, researchers and healthcare professionals can identify prevalent medications, assess adherence to treatment guidelines, uncover potential gaps or areas for improvement in patient care, and gain insights into the evolving landscape of cardiovascular therapies.


Locations(1)

Peking University Third Hospital

Beijing, Beijing Municipality, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06137885


Related Trials